Skip to main navigation Skip to search Skip to main content

Reader response: Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)580
Number of pages1
JournalNeurology
Volume91
Issue number12
DOIs
StatePublished - Sep 18 2018

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Reader response: Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings'. Together they form a unique fingerprint.

Cite this